3 Overlooked UK Stocks Where Cash Flow Matters More Than The Story

With US 10 year yields retreating as inflation readings soften, cash flows suddenly matter more than story lines. When borrowing costs stop climbing, the discount rate used in many valuations steadies, so mispriced cash rich stocks can stand out. That is where the Undervalued Stocks Based On Cash Flows screener comes in. This article highlights three of its most compelling stocks for investors who are looking for value today.

The three stocks covered next are just a sample of what this idea is pointing to, and the full screen surfaced 41 more companies with equally cash rich and valuation focused stories that are not detailed in this article. If you want to identify and analyze your own highest conviction opportunities from this group, head straight into the Undervalued Stocks Based On Cash Flows screener.

Coats Group (LSE:COA)

Coats Group is a London based manufacturer of industrial threads, structural components and software that sit inside everyday apparel, footwear and technical products. Most of its revenue comes from Apparel at about $773 million, with Footwear adding roughly $568 million and additional segment adjustments of around $256 million. The company is valued at about £1.61b, which puts it firmly in mid cap territory on the London market.

Coats Group sits at the crossroads of apparel, footwear and higher spec materials, which provides exposure to both everyday clothing and performance segments. The integration of OrthoLite and its open cell foam insole technology, together with recycled thread sales growth, illustrates how the business is focusing on premium and more sustainable products while also targeting efficiency gains from large-scale factories and automation. At the same time, debt levels, an uneven dividend record and a relatively new board mean the investment case carries risks. To understand how the valuation and analyst expectations compare with these pressures, it is important to look more closely at detailed forecasts, the cash flow profile and the governance track record.

Coats Group is quietly shifting toward higher value materials and software while its cash flows sit in the spotlight. Get the full picture on how that balance of promise and pressure fits together in the 3 key rewards and 2 important warning signs

Build your own cash flow shortlist

Coats Group and the other two stocks in this list all came from the same screener, but the real edge comes when you fine tune the filters yourself. Use our flexible Screener to combine valuation, cash flow strength, balance sheet quality and dividends, or start with any of our curated Investing Ideas for ready made shortlists.

Foresight Group Holdings (LSE:FSG)

Foresight Group Holdings is a London based asset manager that runs infrastructure, private equity, venture capital and listed funds with a focus on renewable energy, core infrastructure and sustainable real assets. Most of its revenue comes from Real Assets at about £115 million, with Private Equity adding roughly £50 million, and the United Kingdom contributing the bulk of its geographic revenue. The company has a market cap of around £552 million, which puts it in mid cap territory on the London market.

Foresight Group Holdings sits at the heart of long term themes like energy transition and social infrastructure. However, it still holds only modest market shares in its key regions, which leaves room for assets under management to build from here. High reported profit margins and strong return on equity have helped support rising earnings, while recent buybacks indicate management is prepared to return surplus capital as the business scales. On the flip side, reliance on performance fees, concentration in UK and European regulation heavy markets and rising administrative costs all create potential strain if fundraising or investment performance slow. For investors who care about cash flows and disciplined capital allocation, the full story around Foresight Group Holdings is worth a closer look.

Foresight Group Holdings sits at the crossroads of energy transition and real assets, yet its fee mix and capital returns are easy to overlook. See how the full cash flow story stacks up in the analysis report for Foresight Group Holdings.

Diaceutics (AIM:DXRX)

Diaceutics is a Belfast based diagnostics commercialization company that helps pharma and biotech firms get precision medicines to the right patients through its DXRX data and analytics platform. The business generates all of its revenue, around £38 million, from Medical Labs and Research services that combine diagnostic testing data, physician and lab mapping, and disease testing rate tracking. Diaceutics has a market cap of about £123 million, which places it firmly in small cap territory.

Diaceutics brings together a specialist precision medicine platform, fresh profitability and a share price that screens as deeply undervalued on cash flows, which is an unusual mix for a small cap. Revenue grew to about £38 million in 2025 and the company swung to a small profit after a prior year loss, while analysts expect strong earnings and revenue growth from here. At the same time, return on equity is still very low, funding relies entirely on external borrowing and the board is relatively young, so execution needs to improve to justify any rerating. For investors comfortable with focused healthcare platforms and higher funding risk, Diaceutics appears to be a stock where sentiment has lagged the fundamental progress.

Diaceutics combines a fresh profit, a small cap valuation and a precision medicine platform that many investors still overlook. See how the analyst forecasts for Diaceutics fits with its cash flows and what the market might be missing next.

Seeking Fresh Alternatives Beyond These Picks

New stock ideas can move from quiet to breakout quickly. Consider whether and how to use this momentum while these opportunities stay under the radar for now.

• Identify strong cash generators that the market has not fully priced yet by scanning the curated 10 high quality undervalued stocks before any momentum changes.
• Track where robotics demand could build next by reviewing companies in the focused 38 robotics and automation stocks while the story is still forming.
• Explore potential developments in infrastructure by checking the hand picked 36 power grid technology and infrastructure stocks while valuations remain grounded.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com